• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 COVID-19 致病性相关的 SARS-CoV-2 遗传变异。

SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity.

机构信息

Department of Microbiology, Faculty of Science, Mahidol University, 272, Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand.

Pornchai Matangkasombut Center for Microbial Genomics, Department of Microbiology, Faculty of Science, Mahidol University, 272, Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand.

出版信息

Microb Genom. 2021 Dec;7(12). doi: 10.1099/mgen.0.000734.

DOI:10.1099/mgen.0.000734
PMID:34870573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8767342/
Abstract

In this study, we performed genome-wide association analyses on SARS-CoV-2 genomes to identify genetic mutations associated with pre-symptomatic/asymptomatic COVID-19 cases. Various potential covariates and confounding factors of COVID-19 severity, including patient age, gender and country, as well as virus phylogenetic relatedness were adjusted for. In total, 3021 full-length genomes of SARS-CoV-2 generated from original clinical samples and whose patient status could be determined conclusively as either 'pre-symptomatic/asymptomatic' or 'symptomatic' were retrieved from the GISAID database. We found that the mutation 11 083G>T, located in the coding region of non-structural protein 6, is significantly associated with asymptomatic COVID-19. Patient age is positively correlated with symptomatic infection, while gender is not significantly correlated with the development of the disease. We also found that the effects of the mutation, patient age and gender do not vary significantly among countries, although each country appears to have varying baseline chances of COVID-19 symptom development.

摘要

在这项研究中,我们对 SARS-CoV-2 基因组进行了全基因组关联分析,以鉴定与无症状/有症状 COVID-19 病例相关的遗传突变。调整了 COVID-19 严重程度的各种潜在协变量和混杂因素,包括患者年龄、性别和国家,以及病毒的系统发育关系。总共从 GISAID 数据库中检索到了 3021 个源自原始临床样本的全长 SARS-CoV-2 基因组,这些样本的患者状态可以明确确定为“无症状/有症状”或“有症状”。我们发现,位于非结构蛋白 6 编码区的突变 11083G>T 与无症状 COVID-19 显著相关。患者年龄与有症状感染呈正相关,而性别与疾病的发展无显著相关性。我们还发现,尽管每个国家的 COVID-19 症状发生的基线概率似乎不同,但突变、患者年龄和性别对各国的影响并无显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/be590f8606ca/mgen-7-0734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/f104ad0eb10b/mgen-7-0734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/d1ee402cebf1/mgen-7-0734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/be590f8606ca/mgen-7-0734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/f104ad0eb10b/mgen-7-0734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/d1ee402cebf1/mgen-7-0734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/366b/8767342/be590f8606ca/mgen-7-0734-g003.jpg

相似文献

1
SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity.与 COVID-19 致病性相关的 SARS-CoV-2 遗传变异。
Microb Genom. 2021 Dec;7(12). doi: 10.1099/mgen.0.000734.
2
Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.新冠病毒家族聚集性病例中分离的 SARS-CoV-2 的分子流行病学研究。
BMC Med Genomics. 2021 Jun 1;14(1):144. doi: 10.1186/s12920-021-00990-3.
3
The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.新型 SARS-CoV-2 在全球传播六个月后的分子变异程度。
Infect Genet Evol. 2021 Jul;91:104800. doi: 10.1016/j.meegid.2021.104800. Epub 2021 Mar 5.
4
Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.全基因组测序揭示了 SARS-CoV-2 在巴基斯坦的 G614 变异株检测。
PLoS One. 2021 Mar 23;16(3):e0248371. doi: 10.1371/journal.pone.0248371. eCollection 2021.
5
Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.对超过 10000 株 SARS-CoV-2 病毒进行全基因组分析揭示了全球遗传多样性和 NSP6 的靶标区域。
Brief Bioinform. 2021 Mar 22;22(2):1106-1121. doi: 10.1093/bib/bbab025.
6
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.SARS-CoV-2 进化枝的全球动态及其与 COVID-19 流行病学的关系。
Sci Rep. 2021 Apr 19;11(1):8435. doi: 10.1038/s41598-021-87713-x.
7
Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.条形码在研究全球 SARS-CoV-2 变异和系统发育动力学中的陷阱。
Zool Res. 2021 Jan 18;42(1):87-93. doi: 10.24272/j.issn.2095-8137.2020.364.
8
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals.从 COVID-19 个体中对 SARS-CoV-2 基因组和亚基因组片段进行寡核苷酸捕获测序。
PLoS One. 2021 Aug 25;16(8):e0244468. doi: 10.1371/journal.pone.0244468. eCollection 2021.
9
Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure.土耳其 SARS-CoV-2 基因组的突变特征及其对刺突蛋白结构的影响。
PLoS One. 2021 Dec 6;16(12):e0260438. doi: 10.1371/journal.pone.0260438. eCollection 2021.
10
Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.具有和不具有优势突变的 SARS-CoV-2 基因组中 S 和 RdRp 的不同选择动态。
Infect Genet Evol. 2021 Jul;91:104796. doi: 10.1016/j.meegid.2021.104796. Epub 2021 Mar 3.

引用本文的文献

1
Impact of SARS-CoV-2 Variant NSP6 on Pathogenicity: Genetic Analysis and Cell Biology.严重急性呼吸综合征冠状病毒2变体NSP6对致病性的影响:遗传分析与细胞生物学
Curr Issues Mol Biol. 2025 May 14;47(5):361. doi: 10.3390/cimb47050361.
2
Contribution of parasite and host genotype to immunopathology of schistosome infections.寄生虫和宿主基因型对血吸虫感染免疫病理学的贡献。
Parasit Vectors. 2024 May 7;17(1):203. doi: 10.1186/s13071-024-06286-6.
3
Contribution of parasite and host genotype to immunopathology of schistosome infections.寄生虫和宿主基因型对血吸虫感染免疫病理学的作用。

本文引用的文献

1
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study.Covid-19 和性别:女性重症疾病的发病率较低,但死亡率相同——一项观察性研究。
BMC Pulm Med. 2021 Mar 20;21(1):96. doi: 10.1186/s12890-021-01455-0.
2
Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China.在中国武汉住院的 101 例 COVID-19 患者的临床特征及疾病严重程度相关的危险因素分析。
Acta Pharmacol Sin. 2022 Jan;43(1):64-75. doi: 10.1038/s41401-021-00627-2. Epub 2021 Mar 19.
3
Serial interval and incubation period of COVID-19: a systematic review and meta-analysis.
bioRxiv. 2024 Jan 13:2024.01.12.574230. doi: 10.1101/2024.01.12.574230.
4
SARS-CoV-2 Variants by Whole-Genome Sequencing in a University Hospital in Bangkok: First to Third COVID-19 Waves.曼谷一家大学医院通过全基因组测序分析的新冠病毒变异株:新冠疫情的第一至第三波
Pathogens. 2023 Apr 21;12(4):626. doi: 10.3390/pathogens12040626.
5
The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2.nsp6 在 SARS-CoV-2 分子发病机制中的多重作用。
Antiviral Res. 2023 May;213:105590. doi: 10.1016/j.antiviral.2023.105590. Epub 2023 Mar 31.
6
Interpretable and Predictive Deep Neural Network Modeling of the SARS-CoV-2 Spike Protein Sequence to Predict COVID-19 Disease Severity.用于预测COVID-19疾病严重程度的SARS-CoV-2刺突蛋白序列的可解释性和预测性深度神经网络建模
Biology (Basel). 2022 Dec 8;11(12):1786. doi: 10.3390/biology11121786.
7
Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning.基于混合效应机器学习的 SARS-CoV-2 刺突蛋白序列预测 COVID-19 疾病严重程度。
Comput Biol Med. 2022 Oct;149:105969. doi: 10.1016/j.compbiomed.2022.105969. Epub 2022 Aug 17.
8
Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.利用 SARS-CoV-2 全基因组测序和电子健康记录数据预测 2020 年 3 月至 2021 年 5 月的严重 COVID-19 模型。
PLoS One. 2022 Jul 12;17(7):e0271381. doi: 10.1371/journal.pone.0271381. eCollection 2022.
9
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.孟买市 AZD1222(ChAdOx1)疫苗突破性感染的基因组分析。
Int J Clin Pract. 2022 Feb 11;2022:2449068. doi: 10.1155/2022/2449068. eCollection 2022.
10
Exploring the Lethality of Human-Adapted Coronavirus Through Alignment-Free Machine Learning Approaches Using Genomic Sequences.利用基因组序列通过无比对机器学习方法探索适应人类的冠状病毒的致死性。
Curr Genomics. 2021 Dec 31;22(8):583-595. doi: 10.2174/1389202923666211221110857.
新型冠状病毒肺炎的潜伏期和传染期:系统回顾和荟萃分析。
BMC Infect Dis. 2021 Mar 11;21(1):257. doi: 10.1186/s12879-021-05950-x.
4
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
5
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.刺突 D614G 突变增加了 SARS-CoV-2 对多种人类细胞类型的感染。
Elife. 2021 Feb 11;10:e65365. doi: 10.7554/eLife.65365.
6
Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area.性别差异在 2019 冠状病毒病的易感性、严重程度和结局中的作用:来自美国多元化大都市地区的横断面分析。
PLoS One. 2021 Jan 13;16(1):e0245556. doi: 10.1371/journal.pone.0245556. eCollection 2021.
7
Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.刺突蛋白D614G和RNA依赖的RNA聚合酶P323L:与新冠病毒疾病严重程度相关的严重急性呼吸综合征冠状病毒2突变
Genomics Inform. 2020 Dec;18(4):e44. doi: 10.5808/GI.2020.18.4.e44. Epub 2020 Dec 7.
8
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
9
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.全球 COVID-19 荟萃分析显示,男性性别是死亡和 ICU 入院的风险因素。
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
10
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者的性别、年龄及合并症与死亡率的关联:一项系统综述和荟萃分析
Intervirology. 2020 Dec 9:1-12. doi: 10.1159/000512592.